curevac nasdaqcvac shares are trading lower after the company announced its strategic decision to adjust the longterm footprint of the external european manufacturing network for its mrna product pipeline the decision was made in response to the reduced shortterm peak demand for vaccines curevacs stock has been falling tuesday down 875 to a price of 6027 the stocks current volume for the day is 70933 thousand which is approximately 10289 of its previous 30day average volume of 68940 thousand the stocks 50day moving average was 6123 at the time this article was published over the past fiftytwo weeks the price has risen as high as 1518 and fallen to a low of 430 benzinga pro provides investors with timely and accurate explanations of why a stock is moving subscribe to receive realtime alerts explaining stock price movements click here to learn more